Used in research settings to detect and quantify prostate-specific membrane antigen (PSMA) levels in biological samples. Helps in studying prostate cancer progression, evaluating therapeutic responses, and developing targeted treatments. Commonly applied in immunoassay development, biomarker validation, and preclinical studies involving PSMA expression. Supports investigation of tumor biology and monitoring of disease recurrence in research models.